Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
    July 2021
  1. ZHU P, Lu J, Zhi X, Zhou Y, et al
    tRNA-derived fragment tRF Lys-CTT-010 promotes triple-negative breast cancer progression by regulating glucose metabolism via G6PC.
    Carcinogenesis. 2021 Jul 3. pii: 6314212. doi: 10.1093.
    >> Share

    May 2021
  2. COOGAN PF, Rosenberg L, Palmer JR, Cozier YC, et al
    Hair product use and breast cancer incidence in the Black Women's Health Study.
    Carcinogenesis. 2021 May 20. pii: 6278856. doi: 10.1093.
    >> Share

    February 2021
  3. ZHOU B, Huang WH, Chen S, Chen W, et al
    GDF15 serves as a coactivator to enhance KISS-1 gene transcription through interacting with Sp1.
    Carcinogenesis. 2021;42:294-302.
    >> Share

  4. SINGHAL J, Chikara S, Horne D, Awasthi S, et al
    Targeting RLIP with CRISPR/Cas9 controls tumor growth.
    Carcinogenesis. 2021;42:48-57.
    >> Share

    January 2021
  5. LIU Y, Zhang A, Bao PP, Lin L, et al
    MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes.
    Carcinogenesis. 2021 Jan 22. pii: 6106539. doi: 10.1093.
    >> Share

  6. REN L, Guo D, Wan X, Qu R, et al
    EYA2 upregulates miR-93 to promote tumorigenesis of breast cancer by targeting and inhibiting the STING signaling pathway.
    Carcinogenesis. 2021 Jan 15. pii: 6101153. doi: 10.1093.
    >> Share

    September 2020
  7. N HAINES C, Klingensmith HD, Komara M, Burd CJ, et al
    GREB1 regulates PI3K/Akt signaling to control hormone-sensitive breast cancer proliferation.
    Carcinogenesis. 2020 Sep 7. pii: 5902307. doi: 10.1093.
    >> Share

    August 2020
  8. CHATTERJEE S, Chatterjee A, Jana S, Dey S, et al
    Transforming growth factor beta orchestrates PD-L1 enrichment in tumor derived exosomes and mediates CD8 T cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
    Carcinogenesis. 2020 Aug 24. pii: 5896493. doi: 10.1093.
    >> Share

    July 2020
  9. GARCIA-VENZOR A, Mandujano-Tinoco EA, Ruiz-Silvestre A, Sanchez JM, et al
    LncMat2B regulated by severe hypoxia induces cisplatin resistance by increasing DNA damage repair and tumor-initiating population in breast cancer cells.
    Carcinogenesis. 2020 Jul 25. pii: 5876306. doi: 10.1093.
    >> Share

  10. GEARHART-SERNA LM, Davis JB, Jolly MK, Jayasundara N, et al
    A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells.
    Carcinogenesis. 2020 Jul 25. pii: 5880241. doi: 10.1093.
    >> Share

  11. SHEN J, Song R, Chow WH, Zhao H, et al
    Homologous recombination repair capacity in peripheral blood lymphocytes and breast cancer risk.
    Carcinogenesis. 2020 Jul 21. pii: 5874561. doi: 10.1093.
    >> Share

    June 2020
  12. PING J, Guo X, Ye F, Long J, et al
    Differences in gene-expression profiles in breast cancer between African and European-ancestry women.
    Carcinogenesis. 2020 Jun 8. pii: 5854539. doi: 10.1093.
    >> Share

    April 2020
  13. PING J, Guo X, Ye F, Long J, et al
    Differences in Gene-Expression Profiles in Breast Cancer between African and European-ancestry Women.
    Carcinogenesis. 2020 Apr 8. pii: 5817819. doi: 10.1093.
    >> Share

    February 2020
  14. SHIMAMOTO K, Tanimoto K, Fukazawa T, Nakamura H, et al
    GLIS1, a novel hypoxia-inducible transcription factor, promotes breast cancer cell motility via activation of WNT5A.
    Carcinogenesis. 2020 Feb 12. pii: 5734484. doi: 10.1093.
    >> Share

    January 2020
  15. HUANG G, Song C, Wang N, Qin T, et al
    RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness.
    Carcinogenesis. 2020 Jan 20. pii: 5710713. doi: 10.1093.
    >> Share

  16. UDQUIM KI, Zettelmeyer C, Banday AR, Lin SH, et al
    APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
    Carcinogenesis. 2020 Jan 13. pii: 5700878. doi: 10.1093.
    >> Share

    November 2019
  17. FANG K, Hu C, Zhang X, Hou Y, et al
    LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK ssignalling pathway.
    Carcinogenesis. 2019 Nov 30. pii: 5648151. doi: 10.1093.
    >> Share

  18. CHEN M, Zou S, He C, Zhou J, et al
    Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.
    Carcinogenesis. 2019 Nov 12. pii: 5622737. doi: 10.1093.
    >> Share

    October 2019
  19. PEENEY D, Jensen SM, Castro NP, Kumar S, et al
    TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer.
    Carcinogenesis. 2019 Oct 17. pii: 5588840. doi: 10.1093.
    >> Share

    August 2019
  20. WANG K, Tu Y, Wan JB, Chen M, et al
    Synergistic anti-breast cancer effect of pulsatilla saponin D and camptothecin through interrupting autophagic-lysosomal function and promoting p62-mediated ubiquitinated protein aggregation.
    Carcinogenesis. 2019 Aug 27. pii: 5554930. doi: 10.1093.
    >> Share

    May 2019
  21. PARK YY, Yun Jung S, Jennings NB, Rodriguez-Aguayo C, et al
    FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
    Carcinogenesis. 2019 May 7. pii: 5486539. doi: 10.1093.
    >> Share

    April 2019
  22. ZOU Y, Zheng S, Xiao W, Xie X, et al
    circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.
    Carcinogenesis. 2019 Apr 17. pii: 5475217. doi: 10.1093.
    >> Share

    March 2019
  23. ISHIGURO J, Ito H, Tsukamoto M, Iwata H, et al
    A functional single nucleotide polymorphism in ABCC11, rs17822931, is associated with the risk of breast cancer in Japanese.
    Carcinogenesis. 2019 Mar 18. pii: 5382612. doi: 10.1093.
    >> Share

    February 2019
  24. TANG H, Chen B, Liu P, Xie X, et al
    SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Carcinogenesis. 2019 Feb 27. pii: 5366034. doi: 10.1093.
    >> Share

  25. SENTHIL KUMAR KJ, Gokila Vani M, Hsieh HW, Lin CC, et al
    MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-kappaB signaling.
    Carcinogenesis. 2019 Feb 1. pii: 5307244. doi: 10.1093.
    >> Share

    January 2019
  26. MUNIRAJ N, Siddharth S, Nagalingam A, Walker A, et al
    Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells.
    Carcinogenesis. 2019 Jan 29. pii: 5303994. doi: 10.1093.
    >> Share

  27. BANERJEE A, Birts CN, Darley M, Parker R, et al
    Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization.
    Carcinogenesis. 2019 Jan 22. pii: 5292622. doi: 10.1093.
    >> Share

  28. HARQUAIL J, LeBlanc N, Ouellette RJ, Robichaud GA, et al
    MiRNAs 484 and 210 Regulate Pax-5 Expression and Function in Breast Cancer Cells.
    Carcinogenesis. 2019 Jan 3. pii: 5272434. doi: 10.1093.
    >> Share

    December 2018
  29. WIDATALLA SE, Korolkova OY, Whalen DS, Goodwin JS, et al
    Lapatinib induced Annexin A6 up-regulation as an adaptive response of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
    Carcinogenesis. 2018 Dec 27. pii: 5263981. doi: 10.1093.
    >> Share

    October 2018
  30. GONG Z, Wang J, Wang D, Buas MF, et al
    Differences in microRNA expression in breast cancer between women of African and European ancestry.
    Carcinogenesis. 2018 Oct 13. pii: 5128950. doi: 10.1093.
    >> Share

  31. HAO S, Chen X, Wang F, Shao Q, et al
    Breast cancer cells-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells.
    Carcinogenesis. 2018 Oct 13. pii: 5128955. doi: 10.1093.
    >> Share

    August 2018
  32. ZHANG X, Wu M, Chong QY, Zhang W, et al
    Amplification of Hsa-miR-191/425 Locus Promotes Breast Cancer Proliferation and Metastasis by Targeting DICER1.
    Carcinogenesis. 2018 Aug 6. pii: 5066751. doi: 10.1093.
    >> Share

    July 2018
  33. HAHN M, Simons CCJM, Weijenberg MP, van den Brandt PA, et al
    Alcohol drinking, ADH1B and ADH1C genotypes, and the risk of postmenopausal breast cancer by hormone receptor status: The Netherlands Cohort Study on Diet and Cancer.
    Carcinogenesis. 2018 Jul 20. pii: 5056811. doi: 10.1093.
    >> Share

  34. PUNGANURU SR, Madala H, Arutla V, Srivenugopal KS, et al
    Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.
    Carcinogenesis. 2018 Jul 13. pii: 5053755. doi: 10.1093.
    >> Share

  35. CHAI C, Wu H, Wang B, Eisenstat DD, et al
    MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
    Carcinogenesis. 2018 Jul 7. pii: 5050474. doi: 10.1093.
    >> Share

  36. KUMAR N, Prasad P, Jash E, Jayasundar S, et al
    cAMP Regulated EPAC1 Supports Microvascular Density, Angiogenic and Metastatic Properties in a Model of Triple Negative Breast Cancer.
    Carcinogenesis. 2018 Jul 5. pii: 5049417. doi: 10.1093.
    >> Share

    June 2018
  37. MOTA M, Jackson WP, Bailey SK, Vayalil P, et al
    Deficiency of Tumor Suppressor Merlin Facilitates Metabolic Adaptation by co-operative Engagement of SMAD-Hippo Signaling in Breast Cancer.
    Carcinogenesis. 2018 Jun 9. pii: 5035377. doi: 10.1093.
    >> Share

    May 2018
  38. BAK MJ, Furmanski P, Shan NL, Lee HJ, et al
    Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer.
    Carcinogenesis. 2018 May 26. pii: 5004853. doi: 10.1093.
    >> Share

    March 2018
  39. LI Y, Liu X, Gong P, Tian X, et al
    Bufalin Inhibits Human Breast Cancer Tumorigenesis by Inducing Cell Death through the ROS-Mediated RIP1/RIP3/PARP-1 Pathways.
    Carcinogenesis. 2018 Mar 13. pii: 4931479. doi: 10.1093.
    >> Share

    January 2018
  40. ZHAO K, Yao Y, Luo X, Lin B, et al
    LYG-202 Inhibits Activation of Endothelial Cells and Angiogenesis through CXCL12/CXCR7 Pathway in Breast Cancer.
    Carcinogenesis. 2018 Jan 30. pii: 4829443. doi: 10.1093.
    >> Share

  41. BRINTON LA, Figueroa JD, Ansong D, Nyarko KM, et al
    Skin Lighteners and Hair Relaxers as Risk Factors for Breast Cancer: Results from the Ghana Breast Health Study.
    Carcinogenesis. 2018 Jan 6. pii: 4792875. doi: 10.1093.
    >> Share

    December 2017
  42. RINCON-FERNANDEZ D, Culler MD, Tsomaia N, Moreno-Bueno G, et al
    In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines.
    Carcinogenesis. 2017 Dec 19. pii: 4762760. doi: 10.1093.
    >> Share

    November 2017
  43. MUTI P, Donzelli S, Sacconi A, Hossain A, et al
    MiRNA-513a-5p Inhibits Progesterone Receptor Expression and Constitutes a Risk Factor For Breast Cancer: The ORDET Prospective Study.
    Carcinogenesis. 2017 Nov 4. doi: 10.1093.
    >> Share

    October 2017
  44. PORE SK, Hahm ER, Latoche JD, Anderson CJ, et al
    Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate.
    Carcinogenesis. 2017 Oct 11. doi: 10.1093.
    >> Share

  45. RENAULT AL, Mebirouk N, Cavaciuti E, Le Gal D, et al
    Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
    Carcinogenesis. 2017;38:994-1003.
    >> Share

    September 2017
  46. LI SS, Xu LZ, Zhou W, Yao S, et al
    p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.
    Carcinogenesis. 2017 Sep 12. doi: 10.1093.
    >> Share

  47. YANG F, Wang Y, Li Q, Cao L, et al
    Intratumor heterogeneity predicts metastasis of triple-negative breast cancer.
    Carcinogenesis. 2017;38:900-909.
    >> Share

  48. FRANCESCHI S, Spugnesi L, Aretini P, Lessi F, et al
    Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
    Carcinogenesis. 2017;38:938-943.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016